Free Trial

SA Halts AstraZeneca Rollout; Analysts Hopeful for Reforms at SONA

SOUTH AFRICA

LOCAL NEWS

  • SA halts AstraZeneca vaccine rollout as new study shows low efficacy against the SA variant (22%) potentially hurting SA's rollout timeline as ~60-70% of SA's vaccines were due to come from AstraZeneca.
    • Plan shifts towards receiving more J&J vaccines which has seen more success so far (85%).
    • Health Dept says it is still awaiting info from its scientists on how to proceed
  • State of the Nation Address (SONA) pegged for Thursday.
    • Analysts hoping for more concrete details on vaccine rollout, reform agenda (economic reconstruction & recovery plan), objectives/frameworks for SOEs and less pie in the sky dreams about smart cities etc.
    • Most see the Feb budget as being a better indicator of economic performance going forward
MNI London Bureau | +44 020-3983-7894 | murray.nichol@marketnews.com
MNI London Bureau | +44 020-3983-7894 | murray.nichol@marketnews.com

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.